Shots: The WAC cost of Mvasi and Kanjinti is 15% lower than their reference products i.e Avastin and Herceptin respectively. Mvasi is available at WAC of $677.40/100 mg and $2,709.60/400 […]readmore
Tags : Kanjinti
Biosimilars
Regulatory
Amgen and Allergan’s Kanjinti (biosimilar, trastuzumab) Receive the US FDA’s
Shots: The FDA’s approval is based on the totality of evidence which includes extensive comparative analytical, pharmacokinetic and clinical data demonstrating that Kanjinti is highly similar and have no clinical […]readmore